Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation).

[1]  H. Suryapranata,et al.  A meta-analytic overview of thrombectomy during primary angioplasty. , 2013, International journal of cardiology.

[2]  G. Stone,et al.  Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. , 2012, Archives of internal medicine.

[3]  G. De Luca,et al.  Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials , 2009, European heart journal.

[4]  G. De Luca,et al.  Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty , 2009, Thrombosis and Haemostasis.

[5]  G. De Luca,et al.  Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. , 2009, The American journal of emergency medicine.

[6]  G. Stone,et al.  Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2009, International journal of cardiology.

[7]  G. Biondi-Zoccai,et al.  Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials. , 2008, Annals of emergency medicine.

[8]  G. Stone,et al.  Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. , 2008, International journal of cardiology.

[9]  J. Ottervanger,et al.  Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. , 2007, International journal of cardiology.

[10]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[11]  E. Antman,et al.  Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2005, JAMA.

[12]  J. Ottervanger,et al.  Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. , 2005, European heart journal.

[13]  J. J. Griffin,et al.  Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction: Results From the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial , 2004, Circulation.

[14]  G. Stone,et al.  Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). , 2000, The American journal of cardiology.

[15]  R. Califf,et al.  Effect of age on outcome with primary angioplasty versus thrombolysis. , 1999, Journal of the American College of Cardiology.

[16]  J. Gurwitz,et al.  Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). , 1998, The American journal of cardiology.

[17]  J. Headrick.  Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation. , 1998, Journal of molecular and cellular cardiology.

[18]  I. Krukenkamp,et al.  Myocardial Cytosolic Calcium Accumulation During Ischemia/Reperfusion: The Effects of Aging and Cardioplegia , 1994, Journal of cardiac surgery.

[19]  S. Levitsky,et al.  Effect of Aging on Intracellular Ca2+, pHi, and Contractilit During Ischemia and Reperfusion , 1992, Circulation.